PPP1R3A and Parkinson disease: Rg1 demonstrates anti-inflammatory properties, which can protect nerve cells and significantly improve PD motor symptoms such as bradykinesia and rigidity, as well as inflammatory-related symptoms (Zhou et al., 2025).